Ketamine

Generic Name
Ketamine
Brand Names
Ketalar
Drug Type
Small Molecule
Chemical Formula
C13H16ClNO
CAS Number
6740-88-1
Unique Ingredient Identifier
690G0D6V8H
Background

Ketamine is an NMDA receptor antagonist with a potent anesthetic effect. It was developed in 1963 as a replacement for phencyclidine (PCP) by Calvin Stevens at Parke Davis Laboratories. It started being used for veterinary purposes in Belgium and in 1964 was proven that compared to PCP, it produced minor hallucinogenic effects and shorter psychotomimetic eff...

Indication

Ketamine is indicated as an anesthetic agent for recommended diagnostic and surgical procedures. If skeletal muscle relaxation is needed, it should be combined with a muscle relaxant. If the surgical procedure involves visceral pain, it should be supplemented with an agent that obtunds visceral pain. Ketamine can be used for induction of anesthesia prior oth...

Associated Conditions
-
Associated Therapies
General Anesthesia, Induction and Maintenance of General Anesthesia

Ketamine for Low Mood States in the ER

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-09-27
Last Posted Date
2020-08-24
Lead Sponsor
Yale University
Target Recruit Count
14
Registration Number
NCT01209845
Locations
🇺🇸

Yale New Haven Hospital Emergency Department, New Haven, Connecticut, United States

The Effect of Peritonsillar Infiltration of Ketamine and Dexamethasone for Postoperative Pain Relief in Children Following Adenotonsillectomy

First Posted Date
2010-09-10
Last Posted Date
2013-05-07
Lead Sponsor
Qazvin University Of Medical Sciences
Target Recruit Count
160
Registration Number
NCT01198210
Locations
🇮🇷

Qazvin university of medical science, Qazvin, Iran, Islamic Republic of

Treatment Resistant Depression (Pilot)

First Posted Date
2010-08-10
Last Posted Date
2023-09-15
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
20
Registration Number
NCT01179009
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Intranasal Ketamine Versus Intramuscular Ketamine for Procedural Sedation in Pediatric Patients

Not Applicable
Terminated
Conditions
Interventions
First Posted Date
2010-07-27
Last Posted Date
2017-07-02
Lead Sponsor
University of Iowa
Target Recruit Count
3
Registration Number
NCT01170247
Locations
🇺🇸

University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States

Fentanyl vs. Low-Dose Ketamine for the Relief of Moderate to Severe Pain in Aeromedical Patients

Not Applicable
Withdrawn
Conditions
Interventions
First Posted Date
2010-07-23
Last Posted Date
2012-06-04
Lead Sponsor
University of Utah
Registration Number
NCT01169025
Locations
🇺🇸

University of Utah Medical Center, Salt Lake City, Utah, United States

Analgesia During Pediatric Digestive Endoscopy: a Comparison of Two Protocols for Procedural Sedation

Phase 4
Completed
Conditions
Interventions
First Posted Date
2010-07-23
Last Posted Date
2014-12-04
Lead Sponsor
Université de Montréal
Target Recruit Count
90
Registration Number
NCT01168492
Locations
🇨🇦

Sainte Justine Hospital, Montreal, Quebec, Canada

The Effect of Ketamine on Attentiveness

Phase 1
Completed
Conditions
Interventions
First Posted Date
2010-07-19
Last Posted Date
2010-08-06
Lead Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Target Recruit Count
24
Registration Number
NCT01165294

Efficacity, Safety and Cost of Intravenous Morphine Titration Alone or Combined to Ketamine

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2010-06-17
Last Posted Date
2010-06-17
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
160
Registration Number
NCT01146145
Locations
🇫🇷

Hopital Louis Mourier, Colombes, France

Effects of Ketamine and Risperidone on Cognition

First Posted Date
2010-06-09
Last Posted Date
2016-11-09
Lead Sponsor
University of Manchester
Target Recruit Count
87
Registration Number
NCT01140620
Locations
🇬🇧

School of Psychology, University of Cardiff, Cardiff, United Kingdom

🇬🇧

Institute of Psychiatry, King's College London, London, Greater London, United Kingdom

🇬🇧

University of Manchester (Dept of Neuropyschiatry), Manchester, United Kingdom

Study of Depression-Ketamine-Brain Function

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2010-06-03
Last Posted Date
2015-12-07
Lead Sponsor
Markus KOSEL
Target Recruit Count
10
Registration Number
NCT01135758
Locations
🇨🇭

Service de Psychiatrie Adulte, Programme dépression, Geneva, Switzerland

© Copyright 2024. All Rights Reserved by MedPath